RANDOMIZED PHASE III TRIAL OF PREOPERATIVE VERSUS POSTOPERATIVE CHEMOTHERAPY WITH CISPLATIN AND GEMCITABINE IN STAGE IB-IIIA NON-SMALL CELL LUNG CANCER NSCLC.
Phase of Trial: Phase III
Latest Information Update: 25 Feb 2012
At a glance
- Drugs Cisplatin (Primary) ; Gemcitabine (Primary)
- Indications Non-small cell lung cancer
- Focus Therapeutic Use
- 25 Feb 2012 Status changed from recruiting to discontinued as reported by European Clinical Trials Database.
- 01 Jun 2011 New trial record